ETX.L - e-Therapeutics plc

LSE - LSE Delayed price. Currency in GBp
Show:
Income statement
Balance sheet
Cash flow

Income statement

Annual
Currency in GBP. All numbers in thousands
Revenue31/01/201931/01/201831/01/201731/01/2016
Total revenue44---
Cost of revenue----
Gross profit44---
Operating expenses
Research development3,6735,01910,9119,965
Selling general and administrative1,4661,7392,0621,590
Non-recurring----
Others----
Total operating expenses5,1396,75812,97311,555
Operating income or loss-5,095-6,758-12,973-11,555
Income from continuing operations
Total other income/expenses net1039-3,225271
Earnings before interest and taxes-5,095-6,758-12,973-11,555
Interest expense----
Income before tax-5,085-6,719-16,198-11,284
Income tax expense-1,086-1,360-3,073-2,464
Minority interest----
Net income from continuing ops-3,999-5,359-13,125-8,820
Non-recurring events
Discontinued operations----
Extraordinary items----
Effect of accounting changes----
Other items----
Net income
Net income-3,999-5,359-13,125-8,820
Preferred stock and other adjustments----
Net income applicable to common shares-3,999-5,359-13,125-8,820
By using Yahoo you agree that Yahoo and partners may use Cookies for personalisation and other purposes